Suven Life Sciences Limited (BOM:530239)

Suven Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 16, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	55,592	24,730	21,742	10,570	13,484	8,961
Market Cap Growth	113.77%	13.74%	105.69%	-21.61%	50.48%	228.97%
Enterprise Value	53,017	23,067	19,870	10,468	13,313	8,934
Last Close Price	210.80	113.40	99.70	48.47	85.47	64.87
Forward PE	-	3.65	3.65	3.65	3.65	3.65
PS Ratio	787.25	371.55	185.94	77.75	112.83	63.67
PB Ratio	19.76	22.48	8.05	2.82	14.03	8.30
P/TBV Ratio	19.78	22.52	8.06	2.82	14.06	8.31
PEG Ratio	-	0.13	0.13	0.13	0.13	0.13
EV/Sales Ratio	-	346.57	169.93	77.00	111.40	63.48
Debt / Equity Ratio	-	-	0.00	0.00	0.03	0.04
Net Debt / Equity Ratio	-0.91	-0.55	-0.89	-0.60	-0.49	-0.38
Net Debt / EBITDA Ratio	0.93	0.36	1.86	1.80	0.39	0.52
Net Debt / FCF Ratio	-	0.31	2.07	1.91	0.32	0.41
Asset Turnover	-	0.03	0.04	0.06	0.10	0.09
Inventory Turnover	-	1.59	2.30	27.66	9.10	0.26
Quick Ratio	-	2.62	18.01	21.03	7.13	3.42
Current Ratio	-	3.21	18.99	22.61	8.01	6.45
Return on Equity (ROE)	-	-84.60%	-32.56%	-50.17%	-119.51%	-57.41%
Return on Assets (ROA)	-	-50.94%	-24.91%	-33.21%	-66.72%	-33.54%
Return on Invested Capital (ROIC)	-1188.91%	-423.40%	-149.73%	-133.77%	-218.87%	-82.85%
Return on Capital Employed (ROCE)	-	-153.30%	-49.50%	-35.00%	-126.60%	-74.00%
Earnings Yield	-4.94%	-6.50%	-4.83%	-11.19%	-9.05%	-8.05%
FCF Yield	-	-7.74%	-5.31%	-11.25%	-10.93%	-11.42%
Dividend Yield	-	-	-	-	1.17%	-
Buyback Yield / Dilution	-2.12%	-	-22.31%	-32.29%	-5.88%	-
Total Shareholder Return	-2.12%	-	-22.31%	-32.29%	-4.71%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.